[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.161.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1961

A New Stabilized Form of Epinephrine for the Treatment of Open-Angle Glaucoma

Author Affiliations

San Francisco
From the Department of Ophthalmology and the Francis I. Proctor Foundation for Research in Ophthalmology, University of California Medical Center, San Francisco.

Arch Ophthalmol. 1961;66(2):232-235. doi:10.1001/archopht.1961.00960010234014
Abstract

A new stabilized form of epinephrine with a pH of 7.4 has been developed * specifically for use in the management of open-angle glaucoma. It is a complex formula as a result of a reaction between epinephrine and boric acid. Its advantages over the forms of epinephrine now in use are that it is nonirritating to ocular tissues and is stable at room temperatures even after the bottle has been opened for more than a month. At least theoretically it has a greater physiologic activity than other forms of epinephrine, since it should penetrate the cornea more easily than the solutions of low pH now available. Also, the lack of irritation means less dilution of the drug by tears. A preliminary clinical trial on a small number of patients with open-angle glaucoma has yielded encouraging results.

Although there were several earlier reports of the use of epinephrine in the treatment of

First Page Preview View Large
First page PDF preview
First page PDF preview
×